Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences

Samankaltaisia teoksia

• Late preconditioning induced by NO donors, adenosine A(1) receptor agonists, and δ(1)-opioid receptor agonists is mediated by iNOS
  Tekijä: Guo, Yiru, et al.
  Julkaistu: (2005)
• Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences
  Tekijä: Li, Qianhong, et al.
  Julkaistu: (2011)
• Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences
  Tekijä: Li, Qianhong, et al.
  Julkaistu: (2011)
• IL-6 plays an obligatory role in late preconditioning via JAK–STAT signaling and upregulation of iNOS and COX-2
  Tekijä: Dawn, Buddhadeb, et al.
  Julkaistu: (2004)
• Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction
  Tekijä: Stein, Adam B., et al.
  Julkaistu: (2004)